Registry update — unassessed
Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)
Trial registry update: COMPLETED. No results reported in the supplied registry record.
OBSERVATIONALMinor significance
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 21, 2026 · Discovered: Sep 23, 2026 · Assessed: — · Research update
What it does not prove
- Observational design cannot establish causation and is susceptible to confounding by indication, unmeasured confounders, and selection bias
- Without reported effect sizes or sample characteristics, the clinical significance and applicability of any comparison cannot be assessed
- This abstract describes the study methodology and goals rather than results, so no clinical outcomes are established
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Observational
- Sample size
- —
- Duration
- —
- Population
- —
- Primary outcome
- —
- Effect size
- —
- Significance
- Not reported
- Journal
- Brigham and Women's Hospital
- Published
- Sep 21, 2026
Sources
Primary source
- Brigham and Women's Hospital ↗Clinical trial
Recorded source passages
Abstract or registry material supplied for assessment; source version 1. This is not a claim of full-text review.
Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials.
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
Sign in to join the discussion.
No comments yet
Be the first to weigh in on this evidence.